Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 11 2019
Historique:
received: 15 11 2018
accepted: 14 10 2019
entrez: 21 11 2019
pubmed: 21 11 2019
medline: 13 11 2020
Statut: epublish

Résumé

This study investigated the characteristics of congenital rubella syndrome (CRS)-associated cardiac complications, particularly patent ductus arteriosus (PDA). We reviewed the medical records of patients with CRS who were admitted to the Children's Hospital 1 in Vietnam between December 2010 and December 2012, and patients with CRS who underwent PDA transcatheter occlusion therapy at the cardiology department between December 2009 and December 2015. We compared the characteristics of PDA treated with transcatheter closure between children with CRS (CRS-PDA) and those without CRS (non-CRS-PDA) who underwent PDA transcatheter closure between July 2014 and December 2015. One-hundred-and-eight children with CRS were enrolled. Cardiac defects (99%), cataracts (72%), and hearing impairment (7%) were detected. Fifty CRS-PDA and 290 non-CRS-PDA patients were examined. CRS-PDA patients had smaller median birthweight (p < 0.001), more frequent pulmonary (p < 0.001) and aortic stenosis (p < 0.001), higher main pulmonary artery pressure, and higher aortic pressure in systole/diastole (p < 0.001 for each) than did non-CRS-PDA patients. The proportion of tubular-type PDA was higher in CRS-PDA patients (16%) than in non-CRS-PDA patients (3%) (p = 0.020). Tubular-type PDA was frequently seen in patients with CRS and accompanied by pulmonary/systemic hypertension and pulmonary/aortic stenosis; in these patients, more cautious device selection is needed for transcatheter PDA closure.

Identifiants

pubmed: 31745134
doi: 10.1038/s41598-019-52936-6
pii: 10.1038/s41598-019-52936-6
pmc: PMC6863812
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17105

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Hypertens Res. 2013 May;36(5):440-3
pubmed: 23364342
J Autism Child Schizophr. 1971 Jan-Mar;1(1):33-47
pubmed: 5172438
Catheter Cardiovasc Interv. 2015 Aug;86(2):E66-72
pubmed: 26032159
Pediatr Int. 2015 Oct;57(5):820-7
pubmed: 26228894
Am J Cardiol. 1989 Apr 1;63(12):877-80
pubmed: 2929450
J Pediatr. 1980 Jan;96(1):88-93
pubmed: 7350322
Eur J Intern Med. 2013 Sep;24(6):562-7
pubmed: 23684500
Catheter Cardiovasc Interv. 2000 Sep;51(1):50-4
pubmed: 10973018
Vaccine. 2001 May 14;19(25-26):3311-9
pubmed: 11348695
Heart. 2002 Mar;87(3):260-3
pubmed: 11847167
Br Heart J. 1956 Oct;18(4):519-22
pubmed: 13374158
Birth Defects Res A Clin Mol Teratol. 2010 Jan;88(1):1-8
pubmed: 19697432
J Pediatr. 1978 Jul;93(1):62-6
pubmed: 650346
Eur J Echocardiogr. 2009 Jan;10(1):1-25
pubmed: 19065003
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):245-52
pubmed: 23460349
Circulation. 2006 Oct 24;114(17):1873-82
pubmed: 17060397
Circulation. 2008 Dec 2;118(23):e714-833
pubmed: 18997169
Vaccine. 2014 Feb 26;32(10):1192-8
pubmed: 24021315
Circulation. 1967 Oct;36(4):544-54
pubmed: 6041868
Circulation. 2013 Dec 3;128(23):2542-5
pubmed: 24297819
Sci Rep. 2017 Apr 13;7:46483
pubmed: 28406248
Vaccine. 2015 Jul 17;33(31):3673-7
pubmed: 26087296
Arch Ophthalmol. 2004 Apr;122(4):541-5
pubmed: 15078672
Pediatrics. 2014 Aug;134(2):e519-26
pubmed: 25002666
Heart. 2016 May;102 Suppl 2:ii14-22
pubmed: 27053693
Can Med Assoc J. 1967 Nov 25;97(22):1329-34
pubmed: 6061597
J Pediatr. 1967 Jul;71(1):59-65
pubmed: 5293860
Postepy Kardiol Interwencyjnej. 2013;9(1):93-6
pubmed: 24570696
Br J Ophthalmol. 1993 Jun;77(6):358-63
pubmed: 8318483
Pediatr Pulmonol. 2004 Jul;38(1):2-22
pubmed: 15170869
Eur Heart J Cardiovasc Imaging. 2017 Mar 1;18(3):254-275
pubmed: 28363204

Auteurs

Michiko Toizumi (M)

Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Department of Global Health, School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.

Cam Giang T Do (CGT)

Department of Cardiology, Children's Hospital 1, Ho Chi Minh City, Vietnam.

Hideki Motomura (H)

Department of Pediatrics, Nagasaki Medical Center, Omura, Japan.

Tin N Do (TN)

Department of Cardiology, Children's Hospital 1, Ho Chi Minh City, Vietnam.

Hirofumi Fukunaga (H)

Department of Pediatrics, Nagasaki University Hospital, Nagasaki, Japan.

Makiko Iijima (M)

Expanded Programme on Immunization, WHO representative office in Viet Nam, Hanoi, Vietnam.

Nhan Nt Le (NN)

Outreach and International Department, Children's Hospital 1, Ho Chi Minh City, Vietnam.

Hung Thanh Nguyen (HT)

Outreach and International Department, Children's Hospital 1, Ho Chi Minh City, Vietnam.

Hiroyuki Moriuchi (H)

Department of Global Health, School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Lay-Myint Yoshida (LM)

Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. lmyoshi@nagasaki-u.ac.jp.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. lmyoshi@nagasaki-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH